Livzon Pharmaceutical Group Inc. (1513.HK) HKSE

30.72

-0.56(-1.79%)

Updated at November 21 03:26PM

Currency In HKD

Valuation

Market Cap23.81B
Enterprise Value16.92B
P/E Ratio14.47
PEG Ratio2.76
Price/Sales Ratio2.67
Price/Book Ratio2.3
Enterprise/Revenue2.09
Enterprise/EBITDA7.61

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.18
Operating Margin0.26

Management Effectiveness

Return On Assets0.09
Return On Equity0.16

Income Statement

Revenue11.81B
Revenue/Share13.33
Gross Profit7.73B
EBITDA3.47B
Net Income2.06B
Diluted EPS2.24

Balance Sheet

Total Cash10.61B
Total Cash/Share11.98
Total Debt3.51B
Total Debt/Equity0.26
Current Ratio2.19
Book Value Per Share16.85

Price History

52-Week Change15.71
52-Week High41.85
52-Week Low24.85
Moving Average 50 Days33.54
Moving Average 200 Days30.92

Statistics

Average Volume1.18M
Shares Outstanding1.06B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.1
Trailing Annual Dividend Yield3.1
Payout Ratio0.75
Last Split Factor13:10
Last Split DateJuly 03, 2019